Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Legend Biotech (NASDAQ: LEGN) reported financial results for the fourth quarter and full year ended December 31, 2025, highlighting continued...
The post Legend Biotech Q4 2025 Earnings Results first appeared on Alphastreet.
ABM Industries (NYSE: ABM) reported financial results for the first quarter of fiscal 2026, delivering solid revenue growth driven by...
The post ABM Industries Q1 FY26 Earnings Results first appeared on Alphastreet.
Revenue Performance Unusual Machines reported robust top-line expansion for the fourth quarter and full year ended December 31, 2025. Full-year...
The post Unusual Machines Q4 FY25 Earnings Results first appeared on Alphastreet.
Revenue Performance ACCO Brands Corporation reported full-year 2025 net sales of $1.525 billion, representing an 8.5 percent decline from the...
The post ACCO Brands Q4 FY25 Earnings Results first appeared on Alphastreet.
TL;DR: Washington is tightening the screws on tech M&A, and the message from regulators is clear: the era of Big...
The post U.S. Regulators Turn Up the Heat on Big Tech Acquisitions first appeared on Alphastreet.
Revenue Growth and Net Income Metrics Sharplink posted substantial top-line expansion for the full year ended December 31, 2025, recording...
The post Sharplink Q4 FY25 Earnings Results first appeared on Alphastreet.
Revenue Performance ARS Pharmaceuticals recorded total revenue of $28.1 million for the fourth quarter of 2025, driven largely by $20.3...
The post ARS Pharmaceuticals Q4 FY25 Earnings Results first appeared on Alphastreet.
Revenue Performance Kohl’s Corporation reported a decline in top-line results for both the fourth quarter and the full fiscal year...
The post Kohl’s Corporation Q4 FY25 Earnings Results first appeared on Alphastreet.
Repay posts $0.24 adjusted EPS on flat $77.7M revenue, with GAAP loss of $6.6M highlighting profitability adjustments ahead of tonight's call.
The post Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss first appeared on test.
CEO Carsten Brunn sold 23,766 shares at $6.82 per share, totaling $162,077, while retaining 323,530 shares.
The post RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares first appeared on test.
Korn Ferry posted Q3 adjusted EPS of $1.28, down 7.6% year-over-year, as revenue of $725M rose 7.2% but slipped sequentially.
The post Korn Ferry (KFY) Q3 Earnings Beat: EPS Rises 7.6% to $1.28 on 7.2% Revenue Growth first appeared on test.
Boundless Bio narrows Q4 loss to $0.58/share and posts first-ever revenue of $17.3M, guiding to $78-80M for 2026.
The post Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share first appeared on test.
CMCT reports Q4 loss of $11.20/share, matching prior quarter but widening sharply from $0.37/share year-ago loss.
The post CMCT Reports Q4 Loss of $11.20/Share first appeared on test.
Vicor's Q4 EPS of $1.10 crushed the $0.48 estimate, yet shares dropped 10.6% as revenue surged 310% sequentially to $452.7M.
The post Vicor (VICR) reported Q4 2025 diluted EPS of $1.01 first appeared on test.
Korn Ferry posts Q3 adjusted EPS of $1.28 on revenue of $725M.
The post BREAKING: KFY Reports Q3 Earnings first appeared on test.
ACCO Brands posts Q4 adjusted EPS of $0.38, flat sequentially but down 2.6% year-over-year, as revenue declines 4.3% to $428.8 million.
The post ACCO Brands adjusted earnings per share of $0.38 for Q4 2025 first appeared on test.
ARS Pharmaceuticals reports Q4 loss of $0.42/share as revenue surges 332% YoY to $28.1M despite sequential decline from Q3 peak.
The post ARS Pharmaceuticals (SPRY) Posts Q4 Loss of $0.42/Share as Revenue Jumps 332% YoY to $28.1M first appeared on test.
VIAV posts Q4 EPS of $0.22, beating estimates by 17%, but shares drop 10% as investors weigh profitability challenges against sequential revenue growth.
The post VIAV Shares Plunge 10% Despite Beating Q4 EPS Estimates by 17% on Profitability Concerns first appeared on test.
Cipher Digital (CIFR) Stock Plunges 10% as Q4 Adjusted Loss of $1.92/Share Misses Estimate by 1,377%
Cipher Digital posts $1.92 loss vs $0.13 estimate as Q4 net loss hits $822M; stock drops 10% on profitability collapse.
The post Cipher Digital (CIFR) Stock Plunges 10% as Q4 Adjusted Loss of $1.92/Share Misses Estimate by 1,377% first appeared on test.
FuelCell Energy reports Q1 loss of $0.91/share, wider than the $0.68 estimate.
The post BREAKING: FCEL Reports Wider Q1 FY26 Loss Than Expected first appeared on test.
FN's Q4 EPS of $3.36 beat estimates by 3.4%, but shares plunged 10% on weak Q1 guidance calling for a 17.9% sequential revenue drop.
The post FN Shares Plunge 10% Despite Earnings Beat as Q1 Revenue Guidance Signals 17.9% Sequential Drop first appeared on test.
Applied Digital narrows Q4 loss to $0.00 vs est. -$0.21, revenue surges 139% to $126.6M, but stock drops 10.5% on margin concerns.
The post APLD Stock Drops 10.5% Despite Crushing Q4 Earnings Estimates as Revenue Surges 139% to $126.6M first appeared on test.
3D Systems posts Q4 adjusted loss of $0.19/share on $111M revenue; no estimate available for comparison.
The post BREAKING: DDD Reports Q4 Earnings first appeared on test.
Ingram Micro's Q4 EPS of $0.96 topped estimates by 6%, but shares plunged 16% on concerns beyond the headline beat.
The post Ingram Micro (INGM) Shares Plunge 16% Despite Q4 EPS Beat of $0.96 first appeared on test.
Bloom Energy's Q4 GAAP EPS beat at $0.45, but adjusted loss of $0.30 and weak Q1 guidance sent shares down 15.5%.
The post Bloom Energy (BE) Shares Plunge 15.5% on Adjusted Loss, Weak Q1 Guidance Despite GAAP EPS Beat first appeared on test.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
